Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Ventas    VTR

VENTAS

(VTR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
46.2(c) 46.7(c) 48.1(c) 48.47(c) 48.98(c) Last
1 513 121 2 159 094 1 203 138 1 017 464 1 973 353 Volume
-1.99% +1.08% +3.00% +0.77% +1.05% Change
More quotes
Financials (USD)
Sales 2020 3 762 M - -
Net income 2020 333 M - -
Net Debt 2020 10 795 M - -
P/E ratio 2020 53,1x
Yield 2020 4,41%
Sales 2021 3 707 M - -
Net income 2021 122 M - -
Net Debt 2021 11 083 M - -
P/E ratio 2021 122x
Yield 2021 3,67%
Capitalization 18 346 M 18 346 M -
EV / Sales 2020 7,75x
EV / Sales 2021 7,94x
Nbr of Employees 516
Free-Float 99,6%
More Financials
Company
Ventas specializes in owning and managing healthcare and medical-residential facilities. At the end of 2019, the group's portfolio included 1,201 assets consisting of rest homes (753), medical office buildings (349), laboratories and research centers (37), rehabilitation and acute care centres (34), special care centers (16), medical and surgical centers (12). Net sales break down geographically as follows: the... 
More about the company
Notations Surperformance© of Ventas
Trading Rating : Investor Rating :
More Ratings
All news about VENTAS
01/08VENTAS : BMO Capital Downgrades Ventas to Underperform From Market Perform, $49 ..
MT
01/06VENTAS : Baird Starts Ventas at Neutral With $49 Price Target
MT
2020VENTAS : Ex-dividend day for
FA
2020INSIDER TRENDS : Insider at Ventas Exercises Options in Mist of 90-Day Buying Tr..
MT
2020VENTAS : Earns Fourth Consecutive Nareit Health Care Leader in the Light Award; ..
BU
2020VENTAS : Morgan Stanley Adjusts Ventas PT to $52 From $39, Maintains Equal Weigh..
MT
2020VENTAS : Declares Fourth Quarter 2020 Dividend of $0.45 per Common Share
BU
2020Raymond James Adjusts Ventas' Price Target to $54 from $47, Keeps Outperform ..
MT
2020BofA Securities Upgrades Ventas to Buy from Underperform, Sets $55 Price Targ..
MT
2020INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Ventas
MT
2020VENTAS : Takes Gold in Nareit's 2020 Diversity, Equity & Inclusion Recognition A..
BU
2020VENTAS : Nareit REITworld Investor Presentation
PU
2020VENTAS : to Participate in Nareit REITworld 2020 Conference
BU
2020KeyBanc Adjusts Ventas' Price Target to $35 From $23, Keeps Underweight Ratin..
MT
2020RBC Capital Adjusts Ventas' Price Target to $54 From $45, Maintains Outperfor..
MT
More news
News in other languages on VENTAS
2020VENTAS : publication des résultats trimestriels
2020VENTAS : Veröffentlichung des Quartalsergebnisses
2020VENTAS : publication des résultats trimestriels
2020VENTAS : Veröffentlichung des Quartalsergebnisses
2020Trump veut porter l'estocade à la "tech" chinoise
More news
Analyst Recommendations on VENTAS
More recommendations
Chart VENTAS
Duration : Period :
Ventas Technical Analysis Chart | VTR | US92276F1003 | MarketScreener
Technical analysis trends VENTAS
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 47,86 $
Last Close Price 48,98 $
Spread / Highest target 16,4%
Spread / Average Target -2,29%
Spread / Lowest Target -28,5%
EPS Revisions
Managers and Directors
NameTitle
Debra A. Cafaro Chairman & Chief Executive Officer
Robert F. Probst Chief Financial Officer & Executive Vice President
Bhavana Devulapally Chief Information Officer & Senior Vice President
Jay M. Gellert Independent Director
James D. Shelton Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
VENTAS-0.12%18 346
WELLTOWER INC.-0.57%26 812
HEALTHPEAK PROPERTIES, INC.-0.89%16 129
MEDICAL PROPERTIES TRUST, INC.-2.75%12 136
OMEGA HEALTHCARE INVESTORS, INC.-1.29%8 138
HEALTHCARE TRUST OF AMERICA, INC.3.81%6 249